首页> 外国专利> IDENTIFICATION OF A DOMAIN IN THE TUMOR NECROSIS FACTOR RECEPTOR FAMILY THAT MEDIATES PRE-LIGAND RECEPTOR ASSEMBLY AND FUNCTION

IDENTIFICATION OF A DOMAIN IN THE TUMOR NECROSIS FACTOR RECEPTOR FAMILY THAT MEDIATES PRE-LIGAND RECEPTOR ASSEMBLY AND FUNCTION

机译:识别介导前配体受体组装和功能的肿瘤坏死因子受体家族中的一个域

摘要

The present invention provides a polypeptide comprising the isolated amino acid sequence of a pre-ligand assembly domain (PLAD) of a TNF-like receptor. Also provided by this invention is a polypeptide comprising the isolated amino acid sequence of a pre-ligand assembly domain (PLAD), wherein the PLAD is selected from the group consisting of: the PLAD of a TNF-R, the PLAD of p60, the PLAD of p80, the PLAD of Fas (CD95/APO-1), the PLAD of TRAIL receptors, the PLAD of LTbetaR, the PLAD of CD40, the PLAD of CD30, the PLAD of CD27, the PLAD of HVEM, the PLAD of OX40 and the PLAD of DR4. TNF-R, p60, p80, Fas, TRAIL receptor, LTbetaR, CD40, CD30, CD27, HVEM, OX40, DR4, TROY, EDAR, XEDAR, DCR3, AITR, 4-1BB, DR3, RANK, TACI, BCMA, DR6, DPG, DR5, DCR1 AND DCR2 are all members of the TNF receptor superfamily or the TNF-like receptor family. The invention also provides the PLAD for other members of the TNF receptor superfamily. The polypeptides of the present invention can be utilized to inhibit oligomerization of members of the TNF receptor superfamily. These polypeptides can also be utilized to inhibit ligand binding to members of the TNF receptor superfamily. The present invention also provides a composition comprising an inhibitor of TNF receptor oligomerization. Further provided by this invention are members of the TNF receptor superfamily that are lacking a PLAD.
机译:本发明提供了一种多肽,其包含TNF样受体的前配体装配结构域(PLAD)的分离的氨基酸序列。本发明还提供了包含前配体装配结构域(PLAD)的分离的氨基酸序列的多肽,其中所述PLAD选自:TNF-R的PLAD,p60的PLAD,所述PLAD的PLAD。 p80的PLAD,Fas(CD95 / APO-1)的PLAD,TRAIL受体的PLAD,LTbetaR的PLAD,CD40的PLAD,CD30的PLAD,CD27的PLAD,HVEM的PLAD,HVD的PLAD OX40和DR4的PLAD。 TNF-R,p60,p80,Fas,TRAIL受体,LTbetaR,CD40,CD30,CD27,HVEM,OX40,DR4,TROY,EDAR,XEDAR,DCR3,AITR,4-1BB,DR3,RANK,TACI,BCMA,DR6 DPG,DR5,DCR1和DCR2都是TNF受体超家族或TNF样受体家族的成员。本发明还提供了TNF受体超家族其他成员的PLAD。本发明的多肽可用于抑制TNF受体超家族成员的寡聚。这些多肽还可以用于抑制配体与TNF受体超家族成员的结合。本发明还提供了包含TNF受体低聚抑制剂的组合物。本发明还提供了缺少PLAD的TNF受体超家族成员。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号